DQ#1: Risk ManagementCase 9-1 discusses Young Again Pharmaceuticals. The three options that this firm has to manage risk are risk retention, risk transfer, or a mixed approach. In 200 ? 250 words, discuss your recommendations on how this company should evaluate and implement these techniques to manage risks.DQ#2: Mitigated RiskGiven your answer to Discussion Forum 1, discuss in 200 ? 250 words what you believe Young Again Pharmaceuticals should focus on once the risks are mitigated.

Leave a Reply

Your email address will not be published.